Nov 14, 2016 | Compliance, Legal, and Malpractice, Laboratory Management and Operations, Laboratory News, Laboratory Operations, Laboratory Pathology, Management & Operations
All hospital laboratories will be part of these programs, and it is an opportunity for medical laboratory professionals to deliver considerable value, as hospitals take steps to improve the utilization of antibiotics
Clinical laboratories and pharmacies in the nation’s hospitals and health systems have a huge opportunity to deliver substantial value in patient care. That’s because, at the start of 2017, hospitals must put effective antimicrobial stewardship programs (ASPs) in place to meet the new accreditation requirements of Medicare and The Joint Commission.
Overuse and inappropriate use of antibiotics is now considered one of the biggest problems in medicine. “Antibiotics are lifesaving drugs, and if we continue down the road of inappropriate use we’ll lose the most powerful tool we have to fight life-threatening infections,” stated Tom Frieden, MD, MPH, Director, Centers for Disease Control and Prevention (CDC) and Administrator, Agency for Toxic Substances and Disease Registry (ATSDR), in a press release issued by the CDC last May. “Losing these antibiotics would undermine our ability to treat patients [who have] deadly infections, cancer, provide organ transplants, and save victims of burns and trauma.”
Much publicity is devoted to the rise of the increase of antibiotic-resistant organisms. In recognition of this problem, the Centers for Medicare and Medicaid Services (CMS), and The Joint Commission (TJC), took steps to add antimicrobial stewardship program requirements to their respective hospital accreditation programs. (more…)
Apr 22, 2015 | Instruments & Equipment, Laboratory Instruments & Laboratory Equipment, Laboratory Management and Operations, Laboratory News, Laboratory Operations, Laboratory Pathology
Hospital-based pathologists may soon gain a new diagnostic assay that could prove effective in detecting hospital-acquired infections more quickly and more accurately than with existing rapid molecular diagnostic tests
Imagine a diagnostic assay designed for hospital settings that uses a specimen of the patient’s breath, can be performed at the bedside, and can detect early-stage infections within two hours of onset. Pathologists and clinical laboratory managers will recognize that a diagnostic test such as this could play a big role in helping hospitals reduce hospital-acquired infections (HAI).
That’s just one application that Madison, Wisconsin-based Isomark has for the new breath analyzer test it is developing. The company says that its diagnostic test is capable of detecting early metabolism and immune system changes based on reading carbon dioxide (CO2) in a patient’s breath.
Canary Could Affect Volume of Clinical Laboratory Specimens
The Isomark Canary Breath Analyzer test (Canary) was specifically designed to identify infections before they have a chance to overwhelm the patient’s immune system. Canary has so many potential uses for identifying infection early that, if the technology were cleared for clinical use, medical laboratories could eventually see a significant reduction in the volume of patient specimens coming into the microbiology department. (more…)
Oct 7, 2013 | Laboratory Hiring & Human Resources, Laboratory Instruments & Laboratory Equipment, Laboratory Management and Operations, Laboratory News, Laboratory Pathology, Management & Operations, News From Dark Daily
A sold-out audience gathered at the seventh annual Lab Quality Confab and heard speakers from the nation’s most innovative medical laboratories share case studies about success in cutting lab expenses and improving quality
DATELINE: NEW ORLEANS, LOUISIANA—At a time when medical laboratories in the United States are experiencing significant financial challenges, there was plenty of guarded optimism among the clinical laboratory managers and pathologists who gathered in this famous city last week for the seventh annual Lab Quality Confab.
One reason for this optimism is that speakers and attendees at this sold-out meeting are the nation’s leading experts in the use of Lean, Six Sigma, and process improvement methods in medical laboratories and pathology groups. They know how to cut lab costs while maintaining quality and boosting the productivity of the lab’s staff and automated systems. (more…)
Oct 23, 2012 | Digital Pathology, Instruments & Equipment, Laboratory News, Laboratory Operations, Laboratory Pathology, Management & Operations
CRM is a new product category for medical laboratory middleware and delivers real-time dashboards that drive higher levels of lab performance and client service
Within the clinical laboratory industry, there’s an interesting conjunction of two fast-moving trends. One trend is the growing use of middleware by medical laboratories of all sizes. The second trend is the goal of converting any type of manual work process in the lab into an automated work process.
These trends often intersect when clinical laboratories and pathology groups use middleware to automate manual processes. One common example is when a lab purchases a middleware solution that handles auto-validation. After implementation, auto-validation eliminates the need for medical technologists to manually review all the individual test results. (more…)
Jun 6, 2011 | Laboratory News, Laboratory Pathology
Clinical pathology laboratory testing played a role in reducing rate of ICU infections
Here’s a big win for improved patient outcomes, and clinical labs and pathologists played a significant role in this achievement. Central line-associated blood stream infections (CLABSI) in ICUs decreased in number by a whopping 58% from 2001 to 2009, according to the Centers for Disease Control and Prevention (CDC).
Some healthcare experts attribute this significant reduction in ICU infections to greater transparency in outcomes data. The CDC’s report, released on March 1, 2011, covered the period from 2001 through 2009. The CDC said that, in 2001, 43,000 ICU patients experienced what today is called a hospital acquired infection (HAI). But by 2009, that number had dropped to 18,000!
The CDC calculates that, thanks to hospital diligence and participation in programs designed to reduce HAIs, at least $1.8 billion and 27,000 lives were saved between 2001 and 2009. However, the CDC noted that other areas of healthcare did not show similar improvements in patient outcomes. (more…)
